Robert R. Krakowiak - 14 Jan 2025 Form 4 Insider Report for Vroom, Inc. (VRM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
14 Mar 2025, 21:59:17 UTC
Prior SEC filing
12 Mar 2024
Next SEC filing
16 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s /Anna-Lisa Corrales, Attorney-in-Fact for Krakowiak, Robert R

Key filing fact

Robert R. Krakowiak filed Form 4 for Vroom, Inc. (VRM) on 14 Mar 2025.

Key facts

  • This page summarizes Robert R. Krakowiak's Form 4 filing for Vroom, Inc. (VRM).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 14 Mar 2025, 21:59.

Change

  • Previous filing in this sequence was filed on 12 Mar 2024.
  • Current net transaction value: +$5,425.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VRM transaction

Common Stock

Award

Transaction value
$0
Shares
+3,820
Change %
+105%
Price
$0.000000
Shares after
7,443
Date
12 Mar 2025
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VRM transaction Derivative

Warrants (Right to buy)

Award

Transaction value
$5,425
Shares
+89
Change %
Price
$60.95
Shares after
89
Date
14 Jan 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
89
Exercise price
$60.95
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents an award of restricted stock units ("RSUs") that vests in full on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting of stockholders following the date of grant and (ii) March 12, 2026. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

Footnote F2

Reflects adjustment of the exercise price pursuant to the automatic conversion of the Common Stock at a ratio of 1-for-5 effectuated by the Amended and Restated Certificate of Incorporation adopted by the Issuer on January 14, 2025.

Footnote F3

Represents the exchange of previously issued shares of Common Stock for issued Common Stock and warrants conducted as part of the 2025 recapitalization plan, with the warrants granting the holder the right to purchase additional shares at a predetermined price.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .